SmartXide Trio: Ultra-pulsed CO₂ Laser
Developed by DEKA, the world’s leading innovator in CO₂ laser technology, SmartXide Trio combines decades of engineering expertise with a market-leading surgical platform for ENT and head & neck procedures.
As DEKA’s exclusive UK partner, Lynton provides the clinical training, technical support and nationwide service infrastructure to ensure your investment is backed long after installation.
From ultra-pulsed precision and advanced scan technology to robotic compatibility and multi-specialty applications, SmartXide Trio is designed to deliver exceptional performance today while supporting the future of laser surgery.
Key Features
SmartXide Trio is becoming the CO₂ platform of choice for an increasing number of NHS ENT departments across the UK. Since its launch, adoption has grown rapidly as more surgeons experience the benefits of ultra-pulsed precision, advanced engineering and dependable UK support.
Backed by DEKA’s globally recognised CO₂ technology, supported by published clinical evidence, and trusted by a growing community of UK users, SmartXide Trio is establishing itself as a proven platform for modern ENT surgery.
“A game-changer for surgical control”
Mr Jim Moore
Consultant ENT Surgeon
Over 1,000 laser systems installed nationwide – supported by one of the UK’s most experienced clinical and engineering teams. Lynton is the UK’s leading supplier of medical and aesthetic laser technology, supporting NHS and private healthcare providers with expert service, training and technical support. Our scale means you’re backed by a dedicated team of highly trained engineers and clinical specialists, providing fast response times and practical support to keep your service running without disruption.
From installation and device training through to day-to-day use, we work alongside your team to ensure your SmartXide Trio performs reliably, consistently and with confidence—helping you maximise the value of your investment for years to come.
– 1,000+ laser systems installed across the UK
– Nationwide engineering team
– Fast response times
– Comprehensive device training
– Ongoing support when you need it
SmartXide Trio supports a broad range of surgical applications.
SmartXide Trio brings together ultra-pulsed CO₂ precision, integrated diode haemostasis and advanced beam delivery in a single, versatile surgical platform. Each technology has been engineered to complement the others, giving surgeons the confidence to cut with precision, maintain a clear operative field and adapt to a wide range of clinical applications.
From delicate vocal cord surgery and airway procedures to transoral robotic surgery (TORS), SmartXide Trio delivers the consistency, control and flexibility required for modern ENT practice. It’s a platform designed not only to meet today’s clinical demands, but to support the future of laser surgery.
A surgical platform combining ultra-pulsed CO₂, 980 nm diode and hollow waveguide fibre delivery for ENT, TORS and soft-tissue applications.
Trio supports ENT microsurgery, stapedotomy, TORS, plastics, dermatology, gynaecology and more.
Ultra Pulse maintains energy above the ablation threshold throughout the pulse, reducing unwanted heat and improving tissue preservation.
Yes. Trio works seamlessly with the CE-marked Robotic Introducer for TORS.
Yes – simplifying procurement and adoption across NHS hospitals.
A unique combination of high-peak CO₂ output, diode haemostasis, flexible hollow fibres and robotic compatibility – all backed by Lynton’s clinical support.
Yes. Trio’s ultra-pulsed CO₂ emission produces short, high-peak pulses that stay above the ablation threshold, limiting lateral heat spread and preserving adjacent structures during delicate soft-tissue work.
The flexible hollow fibre allows surgeons to access anatomically challenging areas where line-of-sight micromanipulation is difficult, supporting precise CO₂ delivery in curved or narrow pathways.
Absolutely. Real-time scanner control, rapid parameter adjustments and ergonomic delivery systems help reduce operative time and minimise surgeon fatigue – supporting smoother, more predictable theatre workflow.
Yes. Its intuitive interface, reproducible energy delivery and visual clarity make it well suited for registrar training, simulation work and supervised cases.
Routine checks and periodic calibration ensure consistent output. Lynton’s technical support team provides servicing, remote diagnostics and on-site assistance to maximise uptime.
The integrated 980 nm diode allows rapid haemostasis in highly vascular areas, improving visibility during surgery and reducing the need for adjunctive cautery.
Yes. Trio is designed with modularity and software upgradability in mind, allowing hospitals to evolve capabilities over time without replacing the entire system.
Yes. Its controlled CO₂ output and scanning options allow precise ablation and resurfacing for selected dermatological, plastic and reconstructive procedures.
Lynton provides comprehensive onboarding, including application training, safety guidance, technique development and ongoing clinical support tailored to ENT and soft-tissue surgical practice.
Yes. Trio’s compact footprint, interchangeable delivery systems and procedural presets allow straightforward adoption into existing ENT, OMFS and head & neck pathways.